-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Here's Why We Think Chemours (NYSE:CC) Might Deserve Your Attention Today
Here's Why We Think Chemours (NYSE:CC) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Chemours (NYSE:CC). Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Chemours with the means to add long-term value to shareholders.
View our latest analysis for Chemours
Chemours' Earnings Per Share Are Growing
If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That means EPS growth is considered a real positive by most successful long-term investors. Chemours managed to grow EPS by 17% per year, over three years. That's a pretty good rate, if the company can sustain it.
Top-line growth is a great indicator that growth is sustainable, and combined with a high earnings before interest and taxation (EBIT) margin, it's a great way for a company to maintain a competitive advantage in the market. The music to the ears of Chemours shareholders is that EBIT margins have grown from 8.2% to 15% in the last 12 months and revenues are on an upwards trend as well. Ticking those two boxes is a good sign of growth, in our book.
You can take a look at the company's revenue and earnings growth trend, in the chart below. For finer detail, click on the image.
NYSE:CC Earnings and Revenue History September 28th 2022The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. While crystal balls don't exist, you can check our visualization of consensus analyst forecasts for Chemours' future EPS 100% free.
Are Chemours Insiders Aligned With All Shareholders?
It's a necessity that company leaders act in the best interest of shareholders and so insider investment always comes as a reassurance to the market. Shareholders will be pleased by the fact that insiders own Chemours shares worth a considerable sum. To be specific, they have US$44m worth of shares. That shows significant buy-in, and may indicate conviction in the business strategy. Even though that's only about 1.2% of the company, it's enough money to indicate alignment between the leaders of the business and ordinary shareholders.
It means a lot to see insiders invested in the business, but shareholders may be wondering if remuneration policies are in their best interest. A brief analysis of the CEO compensation suggests they are. The median total compensation for CEOs of companies similar in size to Chemours, with market caps between US$2.0b and US$6.4b, is around US$6.9m.
Chemours offered total compensation worth US$5.5m to its CEO in the year to December 2021. That is actually below the median for CEO's of similarly sized companies. CEO remuneration levels are not the most important metric for investors, but when the pay is modest, that does support enhanced alignment between the CEO and the ordinary shareholders. It can also be a sign of a culture of integrity, in a broader sense.
Should You Add Chemours To Your Watchlist?
One positive for Chemours is that it is growing EPS. That's nice to see. The fact that EPS is growing is a genuine positive for Chemours, but the pleasant picture gets better than that. Boasting both modest CEO pay and considerable insider ownership, you'd argue this one is worthy of the watchlist, at least. You still need to take note of risks, for example - Chemours has 2 warning signs we think you should be aware of.
Although Chemours certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see insider buying, then this free list of growing companies that insiders are buying, could be exactly what you're looking for.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对于许多投资者,尤其是那些缺乏经验的投资者来说,购买有好故事的公司的股票是很常见的,即使这些公司在亏损。有时,这些故事可能会蒙蔽投资者的头脑,导致他们以自己的情绪投资,而不是投资于良好的公司基本面。亏损的公司可能会像海绵一样吸收资本,因此投资者应该谨慎,不要把钱一笔接一笔地往上扔。
因此,如果这种高风险和高回报的想法不适合,你可能会对盈利的、成长型的公司更感兴趣,比如化学公司(纽约证券交易所代码:CC)。即使这家公司得到了市场的公平估值,投资者也会同意,产生持续的利润将继续为化学公司提供为股东增加长期价值的手段。
查看我们对化学的最新分析
中国化工的每股收益正在增长
如果一家公司能够在足够长的时间内保持每股收益(EPS)的增长,其股价最终应该会随之而来。这意味着,大多数成功的长期投资者认为,每股收益的增长是一个真正的积极因素。在三年的时间里,化学公司设法使每股收益以每年17%的速度增长。这是一个相当不错的比率,如果公司能够维持下去的话。
营收增长是一个很好的指标,表明增长是可持续的,再加上高息税前利润(EBIT)利润率,这是一家公司在市场上保持竞争优势的绝佳方式。Chemour股东听到的消息是,在过去12个月里,息税前利润从8.2%增长到15%,收入也呈上升趋势。在我们的书中,勾选这两个方框是增长的一个好迹象。
你可以在下面的图表中看到该公司的收入和收益增长趋势。要查看更详细的信息,请点击图片。
纽约证券交易所:CC收益和收入历史2022年9月28日作为投资者,诀窍在于找到符合以下条件的公司要去在未来有好的表现,而不仅仅是在过去。虽然水晶球并不存在,但你可以查看我们对分析师对化学公司未来每股收益100%免费预测的可视化。
Chemour的内部人士是否与所有股东一致?
公司领导人以股东的最佳利益行事是必要的,因此,内部投资总是对市场起到安抚作用。股东们将对内部人士持有价值可观的化学股份感到高兴。具体地说,他们拥有价值4400万美元的股票。这显示出大量买入,并可能表明对商业战略的信心。尽管这只占该公司约1.2%的股份,但这笔钱足以表明企业领导人和普通股东之间的关系。
看到内部人士投资于这项业务意义重大,但股东们可能会想,薪酬政策是否符合他们的最佳利益。对CEO薪酬的简要分析表明,情况的确如此。市值在20亿美元至64亿美元之间的公司,其首席执行官的总薪酬中值约为690万美元。
在截至2021年12月的一年里,Chemour向其首席执行官提供了价值550万美元的总薪酬。这实际上低于类似规模公司CEO的中位数。CEO薪酬水平不是投资者最重要的衡量标准,但当薪酬适中时,这确实有助于加强CEO与普通股东之间的一致性。在更广泛的意义上,它也可以是一种诚信文化的标志。
你应该将化学添加到你的观察名单中吗?
化学的一个利好消息是,它的每股收益正在增长。很高兴见到你。每股收益增长的事实对化学来说是一个真正的积极因素,但令人高兴的是,情况还不止于此。你可能会说,这家公司CEO的薪酬不高,内部人士的所有权也相当可观,因此至少值得被列入观察名单。例如,你仍然需要注意风险-化学公司2个警告标志我们认为你应该意识到。
尽管Chemour看起来确实不错,但如果内部人士买入股票,它可能会吸引更多的投资者。如果你想看到内幕交易,那么这本书免费内部人士正在收购的成长型公司名单,可能正是你正在寻找的。
请注意,本文中讨论的内幕交易指的是相关司法管辖区内的应报告交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧